baber/WOPTO huggingface dataset:
Patent WO-2004102431-A1 (WO)
Title: Systeme de programmation d'au moins une tache possedant une pluralite d'activites a realiser par au moins un utilisateur du systeme
Inventor: TENTIJ MAARTEN PETER
IPC: G06Q10/00
Filed: 2004-05-17
Abstract: L'invention concerne un système permettant de programmer au moins une tâche possédant une pluralité d'activités à réaliser par au moins un utilisateur du système. Ce système comprend une unité de stockage servant à contenir des données indiquant un moment de commencement de la tâche, un moment de réalisation de la tâche, des identificateurs destinés aux activités (notamment, les connaissances et les aptitudes nécessaires), des identificateurs destinés aux utilisateurs et des données de programmation qui indiquent l'attribution des activités aux utilisateurs. Ledit système englobe aussi des modèles de projets renfermant au moins une tâche, des modèles d'activités renfermant au moins une des informations suivantes, à savoir, une description, des procédures, des matériaux nécessaires, des aptitudes requises, des liens en ligne, une interface de sélection entre l'unité de stockage et l'utilisateur pour permettre l'attribution des activités à l'utilisateur et la modification des données de programmation destinées à indiquer cette attribution, au moins un utilisateur se voyant attribuer plus d'une activité. Ce système comprend, enfin, une unité de programmation qui sert à définir une pluralité de segments temporels entre le moment du commencement et le moment de la réalisation, qui est sensible aux données de programmation de chacune des activités dans au moins un de ces segments et qui permet de mettre à jour les données de programmation indiquant la programmation.
Patent AU-2004230645-A1 (AU)
Title: Methods and compositions to increase plant resistance to stress
Inventor: BRESSAN RAY A
IPC: C12N15/82
Filed: 2004-04-07
Abstract: Methods and compositions to improve plant stress tolerance are disclosed. An Arabidopsis thaliana MYB8 transcription factor (also known as HOS10) is involved in regulating plant stress response to cold, drought, osmatic stress, phytohormones abcisic acid and salinity.
Patent AU-2004270322-A1 (AU)
Title: Adhesive binding method and device for carrying out this method
Inventor: SCHMIDKONZ PETER
IPC: B26F1/14
Filed: 2004-09-09
Abstract: Adhesive binding method comprises carrying out a perforating process on the folding edge so that two interrupted perforation lines are punched, in which the perforation lines are parallel at a short distance from one another and offset in the longitudinal direction, and forming a widened folding edge. The punch locations of both perforation lines are offset by the length of one perforating tooth along the folding edge. An independent claim is also included for a device for carrying out the method comprising perforating knives with cutting edges (6, 6', 6'') arranged in the direction of two parallel perforating lines (12, 13). The knives are displaced in the direction of their longitudinal axes about a perforating tooth.
Patent AU-2004289835-A1 (AU)
Title: Feed nozzle assembly
Inventor: CHEN YE-MON
IPC: F23D11/46
Filed: 2004-11-11
Abstract: A feed nozzle assembly for introducing a mixture of a gas and a liquid hydrocarbon droplets into a vessel in the form of a substantially sheet-like spray, which feed nozzle assembly comprises a nozzle body provided at its upstream part with means to supply the gas and means to supply the liquid hydrocarbon to said nozzle body and at the downstream end with a closed outlet end which outlet end is provided with an elongated opening wherein in the opening an insert is positioned such that a continuous loop opening results for discharge of the mixture of gas and liquid droplets.
Patent AU-2004308473-A1 (AU)
Title: Methods and compositions for identifying RNA-binding proteins
Inventor: KILK KALLE
IPC: C12N15/11
Filed: 2004-12-22
Abstract: The present invention includes compositions, methods and kits for the identification of a polypeptide that binds to a predetermined RNA sequence. The invention comprises, in part, a photoreactive moiety to aid in identification of such a polypeptide.
Patent WO-2005079897-A1 (WO)
Title: Surveillance cardiaque et therapie a l'aide d'un dispositif fournissant un traitement sous pression pour l'apnee du sommeil
Inventor: PHUAH CHEE KEONG
IPC: A61B5/363
Filed: 2005-02-24
Abstract: L'invention concerne procédé d'utilisation d'un équipement CPAP (ventilation spontanée en pression positive continue), permettant de détecter des oscillations cardiaques dans la respiration d'un patient et de surveiller et de traiter le trouble cardiaque dont souffre le patient. L'appareil diagnostique des conditions de morbidité cardiaque, telles que l'existence d'arythmies ou d'autres anomalies cardiaques, et influence et optimise le volume d'éjection systolique. L'appareil permet également de surveiller le temps de transit en impulsion, des changements dans la phase de pré-éjection et la durée du cycle cardiaque.
Patent AU-2005200632-A1 (AU)
Title: Difference detection methods using matched multiple dyes
Inventor: WAGGONER ALAN
IPC: G01N33/48
Filed: 2005-02-11
Abstract: A process and a kit are provided for detecting differences in two or more samples of protein, including proteins bearing post-translational modifications and peptides. Proteins are prepared, for example, from each of a different group of cell samples or body fluid samples to be compared. Each protein extract is labeled with a different one of a luminescent dye from a matched set of dyes. The matched dyes have generally the same ionic and pH characteristics but emit light at different wavelengths to exhibit a different color upon luminescence detection. The labeled protein extracts are mixed together and separated together by electrophoresis or a chromatographic method. The separation is observed to detect proteins unique to one sample or present in a greater ratio in one sample than in the other. Those unique or excess proteins will fluoresce the color of one of the dyes used. Proteins common to each sample migrate together and fluoresce the same.
Patent AU-2006203309-A1 (AU)
Title: Apparatus, method, and program product for facilitating game play in an electronic lottery game network
Inventor: ENZMINGER JOSEPH R
IPC: G07F17/32
Filed: 2006-08-03
Abstract: At least one pool of game play records is stored at a central processing system. Each game play record includes a record index selected from a set of unique index values, each associated with a different result type. A record index associated with a particular game play record is communicated from the central processing system to the player terminal in response to a game play request which a player has entered at the player terminal. The player terminal responds to the received record index by generating display commands using data at the player terminal to produce a graphic representation at the player terminal. This graphic representation is consistent with the result type associated with the index value comprising the particular record index which has been communicated to the player terminal.
Patent AU-2006227766-A1 (AU)
Title: Wire guides having novel outer surface areas and reservoirs for enhancing hydrophilic properties and delivering therapeutic agents
Inventor: KENNEDY KENNETH II
IPC: A61M25/00
Filed: 2006-03-15
Abstract: Wire guides and methods of using an elongate wire guide with a first end portion and a flexible second end portion having an increased surface area is provided. The second end portion comprises a nominal outer circumference disposed about a longitudinal axis and having a first outer surface including the nominal outer circumference and defining a first surface area. Protuberances, indentations, peaks, and/or valleys are disposed substantially circumferentially about the nominal outer circumference and defining an effective perimeter greater than the nominal outer circumference and having a second outer surface defining a second surface area greater than the first surface area. Hydrophilic materials and therapeutic agents may be disposed partially on the second end portion and a coating, and a membrane may be disposed about second end portion and coating to form reservoirs or lumens for delivering hydrophilic materials and delivering therapeutic agents.
Patent AU-2006264803-A1 (AU)
Title: Novel chemical compounds and the uses thereof as a medicine
Inventor: PRUSS REBECCA
IPC: C07D277/50
Filed: 2006-06-29
Abstract: The present invention relates to the field of pharmacy, especially the treatment of neurodegenerative diseases. The invention specifically relates to a family of chemical compounds for which a neuroprotective activity has been demonstrated. Given that certain members of said family are novel compounds which have never been described, the invention relates to said novel products, the synthesis method thereof and certain novel intermediate synthesis products. The present invention further relates to compositions comprising the compounds of said family, and the use of said compounds as medicaments, especially for the preparation of a medicament for the treatment of neurodegenerative diseases.
Patent AU-2006334744-A1 (AU)
Title: Substituted oxazole derivatives with an analgesic action
Inventor: SUNDERMANN BERND
IPC: C07D263/48
Filed: 2006-12-19
Abstract: 1-aminomethyl-4-oxazolylalkyl-cyclohexane derivatives (I), as racemates, enantiomers, diastereomers (and mixtures), bases and salts with acids are new. 1-aminomethyl-4-oxadiazolylalkyl-cyclohexane derivatives of formula (I), as racemates, enantiomers, diastereomers (and mixtures), bases and salts with acids are new. n : 0-2; R 1>aryl or heteroaryl attached through 1-3C alkyl, both optionally substituted, one or more times; R 2>aryl or heteroaryl, both optionally substituted, one or more times, and/or attached through a 1-3C alkyl; R 3> and R 4>1-6C alkyl (optionally unsaturated, linear or branched, optionally substituted one or more times) or aryl (optionally substituted one or more times and/or attached through 1-3C alkyl) or together they complete a 5-7 membered ring, saturated or unsaturated (but not aromatic), optionally containing an additional heteroatom (S, O or N), optionally substituted one or more times, and the ring may be fused to an aromatic ring; R 5> and R 6>hydrogen or 1-6C alkyl (optionally unsaturated and/or branched), but are not both hydrogen, or together they complete CH 2CH 2OCH 2CH 2 or (CH 2) 3-6; R 7> and R 8>1-4C alkyl (optionally unsaturated and/or substituted one or more times) or (hetero)aryl optionally substituted one or more times and attached through 1-3C alkyl, or together they form a 5-7 membered ring as defined above. An independent claim is included for a method for preparing (I) by reacting aldehyde (A), with amine NHR 4>R 3> (B) and isonitrile amide NC-CHR 1>CONR 7>R 8> (C) in organic solvent, e.g. (m)ethanol, at 30-100, preferably 40-80, [deg]C for 1-10 hours. [Image] [Image] ACTIVITY : Analgesic; Antidepressant; Uropathic; Antidiarrheic; Antipruritic; Antialcoholic; Tranquilizer. MECHANISM OF ACTION : (I) bind to the mu -opioid receptors. The compound [{4-[(4-benzyl-5-pyrrolidin-1-yl-oxazol-2-yl)piperidin-1-ylmethyl]-cyclohexyl}-(4-fluorophenyl)methyl]cyclohexyl}methyl)methylphenylamine caused 76% inhibition of the human mu receptor at a concentration of 1 mu M.
Patent WO-2007095696-A1 (WO)
Title: Polycétide-xanthones et applications
Inventor: CAPON ROBERT JOHN
IPC: C12N1/20
Filed: 2007-02-27
Abstract: La présente invention concerne des polycétide-xanthones de la classe des kibdélones et leur application en tant qu'agents antibactériens et anticancéreux. La présente invention concerne également des méthodes de synthèse de kibdélones, des compositions pharmaceutiques les contenant et leur application dans le traitement des cancers et des infections bactériennes.
Patent WO-2007109857-A1 (WO)
Title: Agent for the treatment of hormone-dependent disorders and uses thereof
Inventor: KLINKEN S PETER
IPC: A61K38/53
Filed: 2007-03-28
Abstract: The present invention relates to novel agents that are useful for treating hormone-dependent disorders. In particular, the present invention relates to A method of modulating a nuclear receptor in vivo comprising the step of administering to a subject in need thereof A nuclear receptor modulating agent comprising a compound or composition capable of altering the endogenous levels of HLS-5 or its activity.
Patent AU-2007240727-A1 (AU)
Title: Immunoglobulin constant region domains with enhanced stability
Inventor: MATSUMURA MASAZUMI
IPC: A61P37/00
Filed: 2007-04-20
Abstract: The invention provides an isolated polypeptide including an immunoglobulin C<SUB>H</SUB>3 region domain polypeptide, or functional fragment thereof, having at least one Pro to GIy substitution and exhibiting enhanced stability, including an enhanced folding rate, compared to an unsubstituted C<SUB>H</SUB>3 domain, wherein the at least one Pro to GIy substitution comprises C<SUB>H</SUB>3 residue Pro38 or a C<SUB>H</SUB>3 domain equivalent thereof. Multimeric complexes of an immunoglobulin C<SUB>H</SUB>3 region domain polypeptide, or functional fragment thereof, having at least one Pro to GIy substitution with a second immunoglobulin C<SUB>H</SUB>3 region domain polypeptide also are provided by the invention. The multimeric complexes can include antibodies, antibody functional fragments such as Fd, Fv, Fab, F(ab'), F(ab)<SUB>2</SUB>, F(ab')<SUB>2</SUB>, single chain Fv (scFv), chimeric antibodies, diabodies, triabodies, tetrabodies or minibody and other binding polypeptides having an immunoglobulin C<SUB>H</SUB>3 region domain polypeptide such as a peptibody or an Fc fusion polypeptide. An isolated population of polypeptides including a plurality of immunoglobulin C<SUB>H</SUB>3 region domain polypeptides, or functional fragments thereof, is further provided. Each C<SUB>H</SUB>3 region domain polypeptide within the populations includes at least one Pro to GIy substitution and exhibits enhanced stability, including an enhanced folding rate, compared to an unsubstituted C<SUB>H</SUB>3 domain, wherein the at least one Pro to GIy substitution comprises C<SUB>H</SUB>3 residue Pro38 or a C<SUB>H</SUB>3 domain equivalent thereof. The invention further provides a method of producing a multimeric binding polypeptide and a method of treating a pathological condition characterized by aberrant cell growth.
Patent AU-2007258202-A1 (AU)
Title: Method for treating diabetic vascular complications
Inventor: WU RONG-TSUN
IPC: C12N15/82
Filed: 2007-06-14
Abstract: The present invention provides a method for treating diabetic vascular complications including administering to a subject in need thereof a therapeutically effective amount of an extract product of a Dioscorea species. The extract product preferably is prepared by a process which involves (a) extracting a tuber of the Dioscorea species with an alcohol-based solvent in the presence of an acetic acid solution to form an extract composition, (b) subjecting a resultant product obtained in step (a) to obtain a soluble fraction, and (c) removing solvent from the soluble fraction obtained in step (b) to obtain the extract product.
Patent WO-2009018622-A1 (WO)
Inventor: LEFEVRE CHRISTOPHE MARC
IPC: A61K38/17
Filed: 2008-08-08
Abstract: The invention relates to cDNA libraries obtained from Tammar wallaby (Macropus eugenii) mammary gland tissue at different times (including day 23 pregnancy, day 130 lactation, and day 260 lactation). Lactation-associated polypeptides were identified from these cDNA libraries, and bovine homologues of the wallaby proteins are also disclosed. The proteins have a range of activities including anti-apoptotic activity, pro- or anti-inflammatory activity, cathelicidin anti-microbial activity, induction of trefoil proteins (and protection of epithelial surfaces), increased cell proliferation, and induction of cell differentiation (and loss of pluripotency).
Patent AU-2009230772-A1 (AU)
Title: Streptococcus Pyogenes Antigens
Inventor: WINKLER BIRGIT
IPC: A61K39/09
Filed: 2009-10-27
Abstract: The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pyogenes, methods for isolating such antigens and specific uses therefor.
Patent AU-2009233674-A1 (AU)
Title: Activation and production of radiolabeled particles
Inventor: MAGILL JOSEPH
IPC: A61K51/12
Filed: 2009-11-06
Abstract: A method for activating particles for internal radiopharmaceutical use, said particles comprising precursor nuclides to be activated, is disclosed. The method comprises: 
directing a high-intensity laser beam (10) onto converting means (12) to produce an irradiating field of protons; and 
irradiating said particles comprising precursor nuclides (18) in said irradiating field of protons to activate said precursor nuclides, thereby obtaining radiolabeled particles.
Patent AU-2009323838-A1 (AU)
Title: Provision of image data
Inventor: ANDREW MAIDEN
IPC: G01T1/29
Filed: 2009-12-04
Abstract: A method and apparatus are disclosed for providing image data. The method includes the steps of providing incident radiation from a radiation source at a target object and, via at least one detector, detecting an intensity of radiation scattered by the target object. Also via the at least one detector an intensity of radiation provided by the radiation source absent the target object is detected. Image data is provided via an iterative process responsive to the intensity of radiation detected absent the target object and the detected intensity of radiation scattered by the target object.
Patent AU-2010201036-A1 (AU)
Title: Production of Modified Glycoproteins Having Multiple Antennary Structures
Inventor: GERNGROSS TILLMAN U
IPC: C12P21/06
Filed: 2010-03-17
Abstract: The present invention relates to eukaryotic host cells, especially lower eukaryotic host cells, having modified oligosaccharides which may be modified further by heterologous expression of a set of glycosyltransferases, sugar and sugar nucleotide transporters to become host-strains for the production of mammalian, e.g., human therapeutic glycoproteins. The process provides an engineered host cell which can be used to express and target any desirable gene(s) involved in glycosylation. Host cells with modified lipid-linked oligosaccharides are created or selected. N-glycans made in the engineered host cells exhibit GnTIII, GnTIV, GnTV, GnT VI or GnTIX activity, which produce bisected and/or multiantennary N-glycan structures and may be modified further by heterologous expression of one or more enzymes, e.g., glycosyltransferases, sugar, sugar nucleotide transporters, to yield human-like glycoproteins. For the production of therapeutic proteins, this method may be adapted to engineer cell lines in which any desired glycosylation structure may be obtained.
Patent AU-2010202451-A1 (AU)
Title: Improved point of contact serum test
Inventor: LEONG LIM PAK
IPC: G01N33/543
Filed: 2010-06-11
Abstract: The present invention provides a method of detecting antibodies or antigens in a liquid specimen comprising: * Placing reagent magnetic particles in a container; * Adding an amount of liquid specimen to the container; * Sedimenting the mixture of the reagent magnetic particles and the liquid specimen; " Adding indicator particles to the container; " Mixing the contents of the container; " Sedimenting the mixture by exposing the container to a magnetic surface.
Patent AU-2010207721-A1 (AU)
Title: FGF21 derivatives with albumin binder A-B-C-D-E- and their use
Inventor: MOLLER TAGMOSE TINA
IPC: A61K38/18
Filed: 2010-01-22
Abstract: The present invention relates to Fibroblast Growth Factor 21 (FGF21), more in particular to derivatives of FGF21 compounds having an albumin binder of the formula A-B- C-D-E- covalently attached. The invention also relates to novel FGF21 analogues, as well as to the pharmaceutical use of these FGF21 derivatives and analogues, in particular for the treatment of diabetes, dyslipidemia, obesity, cardiovascular diseases, metabolic syndrome, and/or Non Alcoholic Fatty Liver Disease (NAFLD). The derivatives of the invention are protracted, e.g. capable of maintaining a low blood glucose level for a longer period of time, capable of increasing the in vivo half-life of FGF21, and/or result in a lower clearance of FGF21. The derivatives of the invention are preferably furthermore of an improved oxidative stability.
Patent AU-2010213925-A1 (AU)
Title: Free standing steel catenary risers
Inventor: SUN LI YOU
IPC: E21B19/00
Filed: 2010-02-08
Abstract: An offshore riser system comprising a tubular from a sea floor to a sea surface comprising a first horizontal portion at the sea floor; a second vertical portion near the sea surface; and a third curved portion located between the first and second portions; and a buoyancy module connected to the second portion, adapted to maintain a shape of the curved portion and enable a connection of a vessel to the second portion.
Patent AU-2010214013-A1 (AU)
Title: A system and method for accessing a structure using a mobile device
Inventor: BENJAMIN ROBERTSON WILLIAM
IPC: H04W12/08
Filed: 2010-01-19
Abstract: A wireless device access system employs short-range wireless communication to require the proximity of a user device to a structure prior to communicating an unlock request. The access system authenticates the unlock request and the proximity of the user to the structure prior to transmitting an unlock command to the structure. Additionally, the wireless device may require the proximity of a user token prior to operation and/or the access system may include an override within the structure blocking any unlock command.
Patent AU-2010216392-A1 (AU)
Title: Direct drive rotary wave energy conversion
Inventor: KENNETH RHINEFRANK
IPC: F03B13/12
Filed: 2010-02-22
Abstract: An apparatus and method for converting wave energy using the relative rotational movement between two interconnected float assemblies and the relative rotational movement between each of the float assemblies and a spar which extends from a connection with the float assemblies at the water surface into the water.
Patent AU-2010226256-A1 (AU)
Title: Pouring device with deformable spout
Inventor: HOLCOMB DAVID A
IPC: A47J43/28
Filed: 2010-02-11
Abstract: A pouring device (100) includes a container (102), a stiffening member (106) with first and second stiffening portions (111, 113) having respective terminating ends (112, 114) spaced from each other. The first and second stiffening portions are coupled to the container with a deformable region (109) of the container being positioned between the terminating ends of the first and second stiffening portions. The deformable region can be more resilient than the stiffening member to form a pour spout at least in part from the deformable region upon application of a force to the container toward opposing sides of the deformable region.
Patent AU-2010236291-A1 (AU)
Title: Use of thaxtomin for selective control of rice and aquatic based weeds
Inventor: DANIEL LEEP
IPC: A01N43/60
Filed: 2010-04-15
Abstract: The use of a bacterial secondary metabolite, thaxtomin is described as an effective herbicide on broadleaved, sedge and grass weeds, e.g., in rice fieIds with no phytotoxicity to rice as well as on aquatic based weeds.